Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Establishment of the Objective Diagnostic Markers and Personalized Medical Intervention in Patients With Major Depressive Disorders (MDD)

NCT02023567 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT02023567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Establishment of the Objective Diagnostic Markers and Personalized Medical Intervention in Patients With Major Depressive Disorders (MDD)
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2013
Completion date
December 31, 2016
Enrollment
2,400 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major